Literature DB >> 18314197

Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.

Eeva Ruotsalainen1, Minna Kardén-Lilja, Pentti Kuusela, Jaana Vuopio-Varkila, Anni Virolainen-Julkunen, Seppo Sarna, Ville Valtonen, Asko Järvinen.   

Abstract

BACKGROUND: Endocarditis has been associated with lower mortality and fewer complications among injection drug users (IDUs) than nonaddicts in Staphylococcus aureus bacteraemia (SAB). The better prognosis of IDUs has not been clarified but it has generally been explained by younger age and other host factors. In this study, bacterial strains, their virulence factors, and host immune responses were compared among IDUs and nonaddicts with SAB, including those with and without endocarditis.
METHODS: A total of 430 consecutive adult patients with methicillin-sensitive SAB were followed prospectively for 3 months. All 44 IDUs were included, and 44 nonaddicts as controls for them. According to the modified Duke criteria, 20 patients in both groups had endocarditis. For each addict without endocarditis, an age and sex matched nonaddict was selected as a control. S. aureus isolates were assigned a genotype by PFGE, Panton-Valentine leukocidin (PVL), staphylokinase (SAK), protease, and haemolysin production. Acute and convalescent sera were tested for antibodies to alpha-haemolysin (ASTA) and teichoic acid (TAA).
RESULTS: There were no differences between IDUs and nonaddicts with SAB in the proportion of patients with a deep infection (98% vs 86%, P=0.06) or a thromboembolic complication (30% vs 14%, P=0.12). Endocarditis among IDUs was not associated with any specific strains, and only the FIN-4 strain was observed more often in IDUs than in nonaddicts (21% vs 5%, P=0.03). The majority of isolates (98%) were PVL negative, and there were no differences in the numbers of SAK, protease and haemolysin production among strains between IDUs and nonaddicts. However, haemolytic properties were found more frequently in strains from IDUs without endocarditis than those with endocarditis (88% vs 47%, P=0.007). IDUs displayed more often elevated TAA titers than nonaddicts, especially in endocarditis at acute phase (33% vs 5%, P=0.04) and at convalescent phase (50% vs 10%, P=0.01). The ASTA titer was more frequently initially positive among IDUs without endocarditis than with endocarditis (44% vs 6%, P=0.01).
CONCLUSIONS: Characterization of the bacterial strains and their virulence factors, and host immune responses did not reveal significant differences between IDUs and nonaddicts with similar clinical picture of SAB. Serological tests were not helpful in identifying patients with endocarditis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314197     DOI: 10.1016/j.jinf.2008.01.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

1.  Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Authors:  Batu K Sharma-Kuinkel; Yuling Wu; David E Tabor; Hoyin Mok; Bret R Sellman; Amy Jenkins; Li Yu; Hasan S Jafri; Thomas H Rude; Felicia Ruffin; Wiley A Schell; Lawrence P Park; Qin Yan; Joshua T Thaden; Julia A Messina; Vance G Fowler; Mark T Esser
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

3.  Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.

Authors:  Yuling Wu; Xu Liu; Ahmad Akhgar; Jia J Li; Hoyin Mok; Bret R Sellman; Li Yu; Lorin K Roskos; Mark T Esser; Alexey Ruzin
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins.

Authors:  Juhsien J C Nienaber; Batu K Sharma Kuinkel; Michael Clarke-Pearson; Supaporn Lamlertthon; Lawrence Park; Thomas H Rude; Steve Barriere; Christopher W Woods; Vivian H Chu; Mercedes Marín; Suzana Bukovski; Patricia Garcia; G Ralph Corey; Tony Korman; Thanh Doco-Lecompte; David R Murdoch; L Barth Reller; Vance G Fowler
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

5.  Genetic polymorphism of the C-reactive protein (CRP) gene and a deep infection focus determine maximal serum CRP level in Staphylococcus aureus bacteremia.

Authors:  T Mölkänen; A Rostila; E Ruotsalainen; M Alanne; M Perola; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-16       Impact factor: 3.267

6.  Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.

Authors:  Dorothee Grumann; Eeva Ruotsalainen; Julia Kolata; Pentti Kuusela; Asko Järvinen; Vesa P Kontinen; Barbara M Bröker; Silva Holtfreter
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

7.  Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.

Authors:  Marijke Peetermans; Thomas Vanassche; Laurens Liesenborghs; Jorien Claes; Greetje Vande Velde; Jakub Kwiecinksi; Tao Jin; Bart De Geest; Marc F Hoylaerts; Roger H Lijnen; Peter Verhamme
Journal:  BMC Microbiol       Date:  2014-12-17       Impact factor: 3.605

8.  Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.

Authors:  David E Tabor; Li Yu; Hoyin Mok; Christine Tkaczyk; Bret R Sellman; Yuling Wu; Vaheh Oganesyan; Tim Slidel; Hasan Jafri; Michael McCarthy; Patricia Bradford; Mark T Esser
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

9.  Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.

Authors:  Xiang-Qing Yu; Gabriel J Robbie; Yuling Wu; Mark T Esser; Kathryn Jensen; Howard I Schwartz; Terramika Bellamy; Martha Hernandez-Illas; Hasan S Jafri
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

10.  Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin.

Authors:  Alexey Ruzin; Yuling Wu; Li Yu; Xiang-Qing Yu; David E Tabor; Hoyin Mok; Christine Tkaczyk; Kathryn Jensen; Terramika Bellamy; Lorin Roskos; Mark T Esser; Hasan S Jafri
Journal:  Clin Transl Immunology       Date:  2018-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.